Please correct me if I'm wrong about this, I only got involved about a month ago. I certainly see that we're not alone in using placental stem cells to create great new drugs, but I believe we're currently the most advanced.
While I'm speaking of Phase 3 Trials, which are year's ahead of those doing Phase 1 Trial, I'm also speaking about something I believe is even more important, production. I'm not suggesting that their is no other way they can ramp up production, but rather wish to suggest that as their drugs prove viable and they need capacity, it might be smarter for them to pay to use our wheel, rather than inventing a new wheel of their own.
Wouldn't it be nice if at absolutely no cost to PSTI they profited from the drugs created by their competitors.
I'm not saying this will be the case, just looking at possibilities. I believe we'll be first to the market with the technology, but we'll also be the leader in production of drugs which utilize it.
I would suspect that at some point an attempt will either be made at a buyout or buy in by one of the big Pharma's. I would prefer the company remain a separate entity by permitting a partnership where the partner takes a substantial equity position, a buy in. I believe trading independently investors do better than if rolled into a big Pharma. The partner in this case has a great deal of control if they own say 25% of the company. First they get one or more seats on the board, but also in any shareholder election they're almost impossible to defeat.
I believe it's only a matter of time as drugs approach approval that such an offer comes in. Whether hostile or friendly such an offer will greatly boost the share price. I could be wrong, but I believe that with approval the company will need the support that such a partnership can bring. If they go it alone, sales growth will probably suffer because of a lack of a network to get the job done.
Gary